Nuvation Bio Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 20.8% | 22.0% | 93.9% | 208.4% | 73.8% | 67.9% | 53.3% | 25.5% | 1.0% | 6.7% | 2.9% | 6.1% | |
| – | 79.2% | -22.0% | 6.1% | -108.4% | 26.2% | 32.1% | 46.7% | 74.5% | 99.0% | 93.3% | 97.1% | 93.9% | |
| – | 5,814.8% | 4,864.4% | 31,659.7% | 3,814.4% | 513.0% | 797.7% | 566.1% | 219.9% | 81.9% | 42.1% | 96.8% | 75.8% | |
| – | 2,075.8% | 2,786.7% | 1,091.0% | 2,597.2% | 445.4% | 1,147.6% | 777.7% | 280.9% | 96.3% | 46.0% | 134.4% | 93.0% | |
| – | 7,890.5% | 7,651.1% | 32,785.6% | 6,508.0% | 970.7% | 1,945.3% | 1,362.4% | 504.6% | 180.3% | 88.6% | 258.2% | 174.9% | |
| – | -7,890.5% | -7,651.1% | -32,779.4% | -6,616.4% | -944.5% | -1,913.2% | -1,315.7% | -430.1% | -81.3% | 4.7% | -161.1% | -81.0% | |
| – | 1,816.3% | 1,816.3% | 9.2% | 16.5% | 1.6% | 1.8% | 8.7% | 49.8% | 15.9% | 8.1% | 21.3% | 15.7% | |
| – | -5,222.3% | -5,603.0% | -32,229.4% | -5,668.5% | -865.8% | -1,726.2% | -1,220.9% | -425.2% | -87.4% | 6.5% | -198.3% | -88.2% | |
| – | 6,604.2% | 5.6% | – | – | – | – | – | – | – | – | – | – | |
| – | -5,222.3% | -5,603.0% | -32,229.4% | -5,668.5% | -865.8% | -1,726.2% | -1,220.9% | -425.2% | -87.4% | 6.5% | -198.3% | -88.2% | |
| – | -5,201.5% | -5,581.1% | -32,203.2% | -5,629.7% | -860.4% | -1,714.4% | -1,204.8% | -417.4% | -70.2% | 15.2% | -175.3% | -74.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.